Antidepressant drugs.

Slides:



Advertisements
Similar presentations
Drugs acting on the CNSI
Advertisements

Other Medicines. Andrenergic Antagonists (Blockers) Bind to receptor site but do not cause an action Bind to receptor site but do not cause an action.
Waqas Tahir GPST2. Overview Introduction Introduction Mechanism of action Mechanism of action Therapeutic uses Therapeutic uses Pharmacokinetics Pharmacokinetics.
Monoamine oxidase inhibitors Monoamine Oxidase Inhibitors (MAOIs) are a class of powerful antidepressant drugs. They are particularly effective in treating.
So far we’ve covered: Acetaminophen (Tylenol) Tamiflu Methylphenidate (Ritalin)
Neurotransmission and the CNS BY PROF. Azza El-Medany.
Drugs on the Brain Emma Robinson RCUK Academic Fellow.
psychoterapeutic Drugs
OPIOIDS NIRALI PATEL (2009) Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology.
Anti-depressants Depression is considered to be due to functional deficit of neurotransmitters like norepinephrine and / or serotonin. Antidepressants.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 32 Antidepressants.
Antidepressant agents By Bohlooli S., Ph.D. School of Medicine, Ardabil University of Medical Sciences.
Joseph De Soto MD, PhD, FAIC
Pharmacology – II PHL-322 CNS Pharmacology
Antidepressant. Management of psychological disorders Medical treatment Psychotherapy Support groups.
Psychotherapeutic Drugs
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
1 ANTI DEPRESSANT DRUGS. 2 3 DEPRESSION INTENSE FEELINGS OF SADNESS INTENSE FEELINGS OF SADNESS HOPELESSNESS HOPELESSNESS DESPAIR DESPAIR INABILITY TO.
1 Clinical Toxicology & Pharmacology Newcastle Mater Misericordiae Hospital Risks of Psychotropics.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 16Psychopharmacology.
Treating Behavioral and Psychological Symptoms of Dementia (BPSD) Kuang-Yang Hsieh, M.D. ph.D. Department of Psychiatry Chimei Medical Center.
Professor of Pharmacology
ANTIDEPRESSANTS New Antidepressants.
Drugs used in Anxiety & Panic Disorders
By S.Bohlooli, Ph.D..  “An affective disorder characterized by loss of interest or pleasure in almost all a person’s usual activities or pastimes.”
Mood Disorders Lesson 24.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 24 Antidepressant Drugs.
Trazodone Mianserin Mirtazapine Tetracyclic Antidepressants Noradrenergic & Specific Serotonergic Antidepressants (NaSSAs) Serotonin Antagonists & Reuptake.
Isahel N. Alfonso, R.N.  Selective Serotonin Reuptake Inhibitor (SSRI) Fluoxetine Fluvoxamine Paroxetine Sertraline Citalopram  Tricyclic Compound (TCA)
Drugs used in Depression- New groups By Prof. Yieldez Bassiouni.
Unit 3 – Neurobiology and Communication
Antidepressant drugs. Mood Disorder  The most common mood disorders are: 1. Major depression (unipolar depression). 2. Manic-depressive illness (bipolar.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF CNS 4 Antidepressant General Pharmacology M212.
for MHD & Therapeutics is proud to present And Now Here Is The Host... Insert Name Here.
Case study Which antidepressant Dr. Matthew Miller.
Antidepressant drugs. Depression: is a disorder of mood rather than disturbance of thought or cognition. It is postulated that depression is due to deficiency.
Anti-depressants Dr. Sanjita Das Range Tricyclics Tetracyclics Selective serotonin reuptake inhibitorsSelective serotonin reuptake inhibitors SSRI Serotonin.
Drugs used in the treatment of affective disorders Dr. Vidumini De Silva.
 : Monoamine hypothesis of depression asserts that depression is caused by functional insufficiency of monoamine neurotransmitter (norepinephrine, serotonin.
ANTIDEPRESSANTS Drugs which can Elevate Mood (Mood Elevators)
Chapter 12: Antidepressants
Drugs used for anxiety and panic disorders
Drugs used for anxiety and panic disorders
Antidepressant Drugs Depression is a disease characterized by feelings of sadness and hopelessness, as well as the inability to experience pleasure in.
ADHD.
Ch. 13: Biomedical Therapy: Biological Approaches to Treatment
Antidepressants.
Drugs used in Depression- Prof. Yieldez Bassiouni
Drugs used in Depression- Prof. Yieldez Bassiouni
AFFECTIVE DISORDERS Anxiety----uneasiness from apprehension and worry about possible events. Try psychotherapy first. benzodiazepenes: xanax/alprazolam.
ANTIDEPRESSANTS 22 Dr. Hiwa K. Saaed 9/19/2018
Antidepressants: pharmacokinetics
PHARMACY TECHNICIAN CHAPTER NINETEEN.
Antidepressants: pharmacodynamics
School of Pharmacy, University of Nizwa
Tricyclic and Tetracyclic Antidepressants Pharmacology and Indications
School of Pharmacy, University of Nizwa
PHARMACOTHERAPY - I PHCY 310
Sertraline In this section we’ll discuss the most relevant aspects of sertraline.
CNS Stimulants Defination
Tricyclic and Tetracyclic Antidepressants Adverse Effects and Pharmacokinetics In this presentation we discuss adverse effects and pharmacokinetics of.
Drugs used in Depression- Prof. Yieldez Bassiouni
Neuroleptic drugs.
Antidepressants.
Neurotransmitters.
Drugs used in Depression-
Neurotransmitters and the Synapse
Treatment of depression
Drugs Used in Depression (New group)
Drugs Used in Depression (Old Group)
Presentation transcript:

Antidepressant drugs

Overview Affecting energy, sleep, appetite, libido and the ability to function. Different from schizophrenia Due to a deficiency of monoamines such as norepinephrine and serotonin at certain key sites in the brain.

Tricyclic /polycyclic antidepressants Block norepinephrine, and serotonin uptake into the neuron. Imipramine, amitriptyline, desipramine All have similar therapeutic efficacy, and the choice of drug depends on tolerance of side effects and duration of action.

Mode of action Inhibition of neurotransmitter uptake: TCA inhibit the neuronal reuptake of norepinephrine, and serotonin into presynaptic nerve terminals. Blocking of receptors: The TCAs also block serotonergic, alpha-adrenergic, histamine, and muscarinic receptors

actions TCAs elevate mood, improve mental alertness, increase physical activity, and reduce morbid preoccupation in 50 to 70% of individuals with major depression.

Therapeutic uses The tricyclic antidepressants are effective in treating severe major depression. Some panic disorders also respond to TCAs. Imipramine has been used to control bed-wetting in children (older than 6 years) by causing contraction of the internal sphincter of the bladder.

Pharmacokinetics Absorption and distribution: The TCAs are well absorbed upon oral administration, are widely distributed and readily penetrate into the CNS. 4 to 17 hours for imipramine.

Adverse effects Antimuscarinic effects: Cardiovascular: Increased catecholamine activity results in cardiac overstimulation Orthostatic hypotension: TCAs block alpha-adrenergic receptors, causing orthostatic hypotension and reflex tachycardia. Sedation

Precautions The tricyclic antidepressants should be used with caution in manic-depressive patients, since they may unmask manic behavior. The tricyclic antidepressants have a narrow therapeutic index

SELECTIVE SEROTONIN-REUPTAKE INHIBITORS The selective serotonin-reuptake inhibitors (SSRI) are a new group of chemically unique antidepressant drugs that specifically inhibit serotonin reuptake. This contrasts with the tricyclic antidepressants that nonselectively inhibit the uptake of norepinephrine, and serotonin, and block muscarinic,

Fluoxetine Actions: Fluoxetine is the prototype of antidepressant drugs that selectively inhibit serotonin reuptake. Fluoxetine is as effective in the treatment of major depression as tricyclic antidepressants. The drug is free of most of the troubling side effects of tricyclic antidepressants

Therapeutic uses The primary indication for fluoxetine is depression. Fluoxetine is effective in treating bulimia nervosa and obsessive-compulsive disorder. The drug has been used for a variety of other indications, including anorexia nervosa, panic disorder, pain associated with diabetic neuropathy, and for premenstrual syndrome.

Pharmacokinetics Fluoxetine and norfluoxetine are slowly cleared from the body, with a 1 to 10 day half-life for the parent compound, and 3 to 30 days for the active metabolite. Fluoxetine is administered orally; with a constant dose, a steady-state plasma concentration of the drug is achieved after several weeks of treatment.

Adverse affects Loss of libido, delayed ejaculation and anorgasmia are probably under-reported side effects often noted by clinicians but are not prominently featured in the list of standard side effects. Overdoses of fluoxetine do not cause cardiac arrhythmias but can cause seizures.

Test List some routes of drug administration, and their important features (8) What is bioavailability? And how to determine it? The factors that influence bioavailability. (7) How to determine Vd if the drug is not eliminated from the body?(4) What are the two types of kinetics of metabolism for most drugs? And how to calculate their velocity simply? (6)